BIIB
Biogen
Health Care
Biotechnology
Cambridge, Massachusetts
Last filing: Feb 6, 2026 (FY2025)
Balance Sheet 17 Accounts • 5 Years
| Account | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| BS_Assets_Cash | $0 | $2.4B | $1.0B | $3.4B | $2.3B |
| BS_Assets_ShortTermInvest | $0 | $179.7M | $416.8M | $1.5B | $1.5B |
| BS_Assets_AcctsReceivable | $0 | $1.4B | $1.7B | $1.7B | $1.5B |
| BS_Assets_Inventory | $0 | $2.5B | $2.5B | $1.3B | $1.4B |
| BS_Assets_PrepaidExpenses | $0 | $752.5M | $1.2B | $1.4B | $740.8M |
| BS_Assets_PPE | $0 | $3.2B | $3.3B | $3.3B | $3.4B |
| BS_Assets_Goodwill | $12.4M | $6.5B | $6.2B | $5.7B | $5.8B |
| BS_Assets_IntangibleAssets | $0 | $9.7B | $8.4B | $1.9B | $2.2B |
| BS_Liab_AcctsPayable | $0 | $424.2M | $403.3M | $491.5M | $589.2M |
| BS_Liab_AccruedLiab | $0 | $0 | $117.5M | $0 | $0 |
| BS_Liab_OtherCurrent | $0 | $2.8B | $2.6B | $2.5B | $2.5B |
| BS_Liab_LongTermDebt | $0 | $6.3B | $6.9B | $6.3B | $6.3B |
| BS_Liab_OtherNoncurrent | $0 | $732.3M | $781.1M | $944.2M | $1.3B |
| BS_Equity_PreferredStock | $0 | $0 | $0 | $0 | $0 |
| BS_Equity_CommonStock | $0 | $100.0K | $100.0K | $100.0K | $100.0K |
| BS_Equity_TreasuryStock | $0 | $3.0B | $3.0B | $3.0B | $3.0B |
| BS_Equity_AOCI | $0 | $-136.2M | $-153.7M | $-164.9M | $-106.7M |